• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

"Normal" Is Not Normal: The Role of the Immune Microenvironment of Adjacent Non-Neoplastic Tissue in Dictating the Biology of Early-Stage NSCLC.

作者信息

Denize Thomas, Mino-Kenudson Mari

机构信息

Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.

出版信息

J Thorac Oncol. 2023 Sep;18(9):1121-1123. doi: 10.1016/j.jtho.2023.07.001.

DOI:10.1016/j.jtho.2023.07.001
PMID:37599044
Abstract
摘要

相似文献

1
"Normal" Is Not Normal: The Role of the Immune Microenvironment of Adjacent Non-Neoplastic Tissue in Dictating the Biology of Early-Stage NSCLC.“正常”并非正常：相邻非肿瘤组织的免疫微环境在早期非小细胞肺癌生物学特性决定中的作用
J Thorac Oncol. 2023 Sep;18(9):1121-1123. doi: 10.1016/j.jtho.2023.07.001.
2
Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.采用系统生物学策略并进行实验验证，揭示西药黄丸治疗非小细胞肺癌的药理机制。
Phytomedicine. 2023 Jan;108:154491. doi: 10.1016/j.phymed.2022.154491. Epub 2022 Oct 17.
3
Tumor Immune Microenvironment and Immunotherapy in Brain Metastasis From Non-Small Cell Lung Cancer.脑转移非小细胞肺癌的肿瘤免疫微环境与免疫治疗
Front Immunol. 2022 Feb 17;13:829451. doi: 10.3389/fimmu.2022.829451. eCollection 2022.
4
Unique Immune Gene Expression Patterns in Bronchoalveolar Lavage and Tumor Adjacent Non-Neoplastic Lung Tissue in Non-Small Cell Lung Cancer.非小细胞肺癌支气管肺泡灌洗液和肿瘤旁非肿瘤性肺组织中的独特免疫基因表达模式。
Front Immunol. 2018 Feb 12;9:232. doi: 10.3389/fimmu.2018.00232. eCollection 2018.
5
Immunotherapy in NSCLC patients with brain metastases. Understanding brain tumor microenvironment and dissecting outcomes from immune checkpoint blockade in the clinic.非小细胞肺癌脑转移患者的免疫治疗。了解脑肿瘤微环境并剖析临床免疫检查点阻断治疗的结果。
Cancer Treat Rev. 2020 Sep;89:102067. doi: 10.1016/j.ctrv.2020.102067. Epub 2020 Jul 7.
6
Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.鉴定和验证与肿瘤微环境相关的基因签名，用于晚期非小细胞肺癌的预后预测。
Biomed Res Int. 2021 Mar 30;2021:8864436. doi: 10.1155/2021/8864436. eCollection 2021.
7
The immune microenvironment in non-small cell lung cancer is predictive of prognosis after surgery.非小细胞肺癌的免疫微环境与手术后的预后相关。
Mol Oncol. 2019 May;13(5):1166-1179. doi: 10.1002/1878-0261.12475. Epub 2019 Apr 10.
8
The Inflammatory CXC Chemokines, GROα, IP-10, and MIG, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression.肿瘤微环境中的炎性CXC趋化因子GROα、IP-10和MIG可作为非小细胞肺癌进展的新指标。
Immunol Invest. 2017 May;46(4):361-374. doi: 10.1080/08820139.2017.1280052. Epub 2017 Apr 4.
9
Prognostic value of RILPL2 and its correlation with tumor immune microenvironment and glycolysis in non-small cell lung cancer.RILPL2 的预后价值及其与非小细胞肺癌肿瘤免疫微环境和糖酵解的相关性。
Cell Cycle. 2023 Apr;22(7):841-857. doi: 10.1080/15384101.2022.2159203. Epub 2022 Dec 19.
10
Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer.抗 PD-1/PD-L1 免疫疗法疗效的分子异质性与东亚非小细胞肺癌患者的肿瘤免疫微环境相关。
Cancer Biol Med. 2020 Aug 15;17(3):768-781. doi: 10.20892/j.issn.2095-3941.2020.0121.

引用本文的文献

1
Peritumoral tissue (PTT): increasing need for naming convention.瘤周组织（PTT）：命名规范需求不断增加。
Br J Cancer. 2024 Oct;131(7):1111-1115. doi: 10.1038/s41416-024-02828-y. Epub 2024 Sep 2.